Company profile
Century Therapeutics, Inc.
NASDAQ:IPSCBiotechnology: Biological Products (No Diagnostic Substances)
Clinical trials (2)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT05336409 | phase1 | terminated | 2023-01-24 | 2025-07-01 | Century Therapeutics, Inc. | A Study of CNTY-101 in Participants With CD19-Positive B-Cell Malignancies |
| NCT06255028 | phase1 | active_not_recruiting | 2025-02-06 | 2028-08-01 | Century Therapeutics, Inc. | A Study of CNTY-101 in Participants With Refractory B Cell-mediated Autoimmune Diseases |
FDA applications (0)
No records yet.